DE69406302D1 - Verwendung von östriolmessungen zur uberwachung tokolytischer therapie - Google Patents

Verwendung von östriolmessungen zur uberwachung tokolytischer therapie

Info

Publication number
DE69406302D1
DE69406302D1 DE69406302T DE69406302T DE69406302D1 DE 69406302 D1 DE69406302 D1 DE 69406302D1 DE 69406302 T DE69406302 T DE 69406302T DE 69406302 T DE69406302 T DE 69406302T DE 69406302 D1 DE69406302 D1 DE 69406302D1
Authority
DE
Germany
Prior art keywords
estriol
measurements
monitor
tocolytic therapy
tocolytic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69406302T
Other languages
English (en)
Other versions
DE69406302T2 (de
Inventor
Vivian Dullien
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Adeza Biomedical Corp
Original Assignee
Biex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biex Inc filed Critical Biex Inc
Application granted granted Critical
Publication of DE69406302D1 publication Critical patent/DE69406302D1/de
Publication of DE69406302T2 publication Critical patent/DE69406302T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743—Steroid hormones

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE69406302T 1993-10-13 1994-07-14 Verwendung von östriolmessungen zur uberwachung tokolytischer therapie Expired - Lifetime DE69406302T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/136,219 US5370135A (en) 1993-10-13 1993-10-13 Use of estriol measurement to monitor tocolytic therapy
PCT/US1994/007892 WO1995010779A1 (en) 1993-10-13 1994-07-14 Use of estriol measurement to monitor tocolytic therapy

Publications (2)

Publication Number Publication Date
DE69406302D1 true DE69406302D1 (de) 1997-11-20
DE69406302T2 DE69406302T2 (de) 1998-03-19

Family

ID=22471884

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69406302T Expired - Lifetime DE69406302T2 (de) 1993-10-13 1994-07-14 Verwendung von östriolmessungen zur uberwachung tokolytischer therapie

Country Status (7)

Country Link
US (1) US5370135A (de)
EP (1) EP0723666B1 (de)
JP (1) JP3522762B2 (de)
AU (1) AU7332794A (de)
DE (1) DE69406302T2 (de)
HK (1) HK1001596A1 (de)
WO (1) WO1995010779A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2103495A (en) * 1994-08-04 1996-03-04 Biex, Inc. Method for prediction of premature delivery using estetrol (e4) as an indicator
US5804452A (en) * 1995-04-27 1998-09-08 Quidel Corporation One step urine creatinine assays
AU2247997A (en) * 1996-01-29 1997-08-20 Savor, Evelyn P. Method of treating undesired uterine contractions using optically pure R-or RR-isomers of adrenergic beta-2 agonists
US5824467A (en) * 1997-02-25 1998-10-20 Celtrix Pharmaceuticals Methods for predicting drug response
US6087090A (en) * 1997-02-25 2000-07-11 Celtrix Pharmaceuticals, Inc. Methods for predicting drug response
SG102538A1 (en) 1998-04-24 2004-03-26 Roche Diagnostics Gmbh Storage container for analytical devices
TR200101882T2 (tr) * 1998-10-29 2001-12-21 Board Of Regents, The University Of Texas System Tiazolidindion türevlerinin erken doğum halinde uterus kasılmalarını veya laktasyonu önlemek için kullanımı
US6174665B1 (en) 1999-09-10 2001-01-16 Biex, Inc. Hormone replacement therapy monitoring
AU2738401A (en) * 1999-12-29 2001-07-09 Aeron Biotechnology, Inc. Saliva assay for steroid hormones
WO2004071427A2 (en) 2003-02-06 2004-08-26 Adeza Biomedical Corporation Screening and treatment methods for prevention of preterm delivery
US7399278B1 (en) 2003-05-05 2008-07-15 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Method and system for measuring amniotic fluid volume and/or assessing fetal weight
WO2005007223A2 (en) * 2003-07-16 2005-01-27 Sasha John Programmable medical drug delivery systems and methods for delivery of multiple fluids and concentrations
CA2534837A1 (en) * 2003-08-06 2005-02-17 Trig Medical Ltd. Method and apparatus for monitoring labor parameters
ATE534750T1 (de) * 2004-07-30 2011-12-15 Adeza Biomedical Corp Onkofetales fibronektin als zervixkarzinom-marker
US7776557B2 (en) * 2006-01-30 2010-08-17 Diagnostic Technologies Ltd. Method for monitoring tocolytic treatment
CA2789238C (en) * 2010-03-09 2020-05-12 Dignity Health Methods for inhibiting preterm labor and uterine contractility disorders and preventing cervical ripening
US20110237906A1 (en) * 2010-03-26 2011-09-29 General Electric Company System and method for graphical display of medical information
US9271991B2 (en) * 2010-10-27 2016-03-01 Dignity Health Trimegestone (TMG) for treatment of preterm birth
BR112018013597A2 (pt) 2016-01-04 2019-01-08 ObsEva S.A. composição farmacêutica, método para tratar ou impedir o trabalho de parto prematuro, método para impedir o trabalho de parto antes do parto cesariana, método para tratar ou impedir a dismenorreia e kit
AU2017205254B2 (en) * 2016-01-04 2021-05-20 Xoma (Us) Lcc Alpha-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt form, crystal polymorph thereof
US11534428B1 (en) 2018-05-16 2022-12-27 Xoma (Us) Llc Compositions and methods for delaying the incidence of labor

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4500523A (en) * 1983-03-15 1985-02-19 Cornell Research Foundation, Inc. Suppression of premature labor by use of aromatase inhibitors

Also Published As

Publication number Publication date
JPH09504108A (ja) 1997-04-22
WO1995010779A1 (en) 1995-04-20
DE69406302T2 (de) 1998-03-19
JP3522762B2 (ja) 2004-04-26
HK1001596A1 (en) 1998-06-26
EP0723666B1 (de) 1997-10-15
AU7332794A (en) 1995-05-04
EP0723666A1 (de) 1996-07-31
US5370135A (en) 1994-12-06

Similar Documents

Publication Publication Date Title
DE69406302D1 (de) Verwendung von östriolmessungen zur uberwachung tokolytischer therapie
DE69034018T2 (de) Kombinierte verwendung von hyaluronsäure und therapeutischen wirkstoffen zur verbesserung des therapeutischen effekts
FI103948B (fi) Kudoksen manipulointi ja ankkurointi
FI941787A0 (fi) Sähkökirurginen prosessori ja menetelmä sen käyttämiseksi
ATA900296A (de) Verwendung von n-glyoxylprolylesterverbindungen in arzneimitteln
DE69715827D1 (de) Verwendung von aloe extrakt enthaltenden zahnprothesehaftmitteln
KR890700360A (ko) 경피 흡수 촉진제 및 이를 함유하는 피부외용 제제
DE69505657T2 (de) Fluorcarbonetherhybriden enthaltende physiologich akzeptabele emulsionen und verwendungsverfahren
ATE256463T1 (de) Pharmazeutische zubereitung zur verwendung in der behandlung von diabetes
DE69600012T2 (de) Verwendung von Salicylsäure-Derivativen zur Hautbleichung
FI960353A0 (fi) Ihmisen interleukiini-10:n agonistit ja antagonistit
EP0351659A3 (en) Method and arrangement for measuring the concentration of optically active substances
DE69522188D1 (de) Verwendung von Substanz P Antagonist im pharmazeutischer Zusammensetzung
ATE217518T1 (de) Verwendung mindestens eines in 6-stellung substituierten pyrimidin-3-oxids zur stimulierung von tyrosinase
DE69434777D1 (de) Verwendung von Relaxin zur Herstellung von therapeutischen Mitteln
DE69531048D1 (de) Verwendung von steroidsulphatase-hemmern
DE69419308D1 (de) Vorrichtung zur bestimmung von physiologischen daten sowie verwendung der vorrichtung
DE69600212D1 (de) Verwendung von Monocarbonsäuren zur Pflege von Keratinsubstanzen
IT8747974A0 (it) Strumento geometrico e procedimento per la sua fabbricazione
DE69324891T2 (de) Detektor zur Detektion von Ereignissen in lebendem Gewebe
DE59308823D1 (de) Verwendung von Thioalkandionen als Aromastoffe
IT8848368A0 (it) Procedimento per analisi di sieroproteine e di lipo-proteine
ATA49889A (de) Pharmazeutische verwendung von agmatin
IT1231929B (it) Corredo di apparecchiature per eseguire cheratomileusi miopica ed ipermetropica
NO922413L (no) Utstyr for bruk i diagnostisering av sykdommer

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: ADEZA BIOMEDICAL CORP.(N.D.GES.D.STAATES DELAWARE)